NNC0165-1875 has recently completed a phase 2 trial in combination with semaglutide 2.4 mg once weekly (NCT04969939), but results are not currently available
For lifestyle counseling, all participants met with registered dietitians who had extensive experience in exercise programming and prescription
Patients seeking support for obesity management in the meantime should speak with their GP, who can refer to NHS Tier 3 weight management services (in line with NICE CG189) or consider currently approved pharmacological options where clinically appropriate
Manufacturer Warnings and FDA Stance on Ozempic and Wegovy Novo Nordisk, the manufacturer of Ozempic and Wegovy, has updated their product labels to include information about potential vision risks
For patients, the implications are immediate and tangible
Talking about weight can be hard, but it is an important part of planning for a healthy pregnancy